These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13718206)

  • 41. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA; Kim HG; Long L
    J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Candida infections with amphotericin B lipid complex.
    Ito JI; Hooshmand-Rad R
    Clin Infect Dis; 2005 May; 40 Suppl 6():S384-91. PubMed ID: 15809924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotype comparisons of strains of Candida albicans from patients with cutaneous candidiasis and vaginal candidiasis.
    She XD; Wang XJ; Fu MH; Shen YN; Liu WD
    Chin Med J (Engl); 2008 Aug; 121(15):1450-5. PubMed ID: 18959125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic analysis of innate immunity in resistance to Candida albicans.
    Tuite A; Mullick A; Gros P
    Genes Immun; 2004 Nov; 5(7):576-87. PubMed ID: 15372070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.
    Spellberg BJ; Ibrahim AS; Avanesian V; Fu Y; Myers C; Phan QT; Filler SG; Yeaman MR; Edwards JE
    J Infect Dis; 2006 Jul; 194(2):256-60. PubMed ID: 16779733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
    Vonk AG; Netea MG; van Krieken JH; Iwakura Y; van der Meer JW; Kullberg BJ
    J Infect Dis; 2006 May; 193(10):1419-26. PubMed ID: 16619190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The affinity of hydroxystilbamidine for psoriatic lesions.
    ROE DA
    Arch Dermatol; 1961 Apr; 83():584-6. PubMed ID: 13742649
    [No Abstract]   [Full Text] [Related]  

  • 48. Attempts to find new chemotherapeutic amidines; nuclear substituted derivatives of 4:4'- and 3:3'-diamidinostilbene.
    ASHLEY JN; HARRIS JO
    J Chem Soc; 1946 Jul; ():567-72. PubMed ID: 20282422
    [No Abstract]   [Full Text] [Related]  

  • 49. The constitution of photostilbamidine, the irradiation product of stilbamidine.
    FULTON JD
    Br J Pharmacol Chemother; 1948 Mar; 3(1):75-9. PubMed ID: 18904727
    [No Abstract]   [Full Text] [Related]  

  • 50. Constitution of the irradiation product from stilbamidine.
    FULTON JD; DUNITZ JD
    Nature; 1947 Aug; 159(4057):161. PubMed ID: 20256179
    [No Abstract]   [Full Text] [Related]  

  • 51. Morphologic effects of stilbamidine; report of autopsies in three stilbamidinetreated cases.
    KANNERSTEIN M
    J Mt Sinai Hosp N Y; 1949; 16(1):47-53. PubMed ID: 18150301
    [No Abstract]   [Full Text] [Related]  

  • 52. The photochemical instability of cis- and trans-4:4'-diamidinostilbene.
    HENRY AJ
    J Chem Soc; 1946 Dec; (12):1156-64. PubMed ID: 20285082
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical & experimental observations on the therapy of Candida mycosis].
    SCHABINSKI G; ESSIGKE G
    Arzneimittelforschung; 1957 Aug; 7(8):507-13. PubMed ID: 13459812
    [No Abstract]   [Full Text] [Related]  

  • 54. [Contribution to the treatment of Candida mycoses of the lungs].
    BAUMANN E
    Munch Med Wochenschr; 1959 Jun; 101(24):1040-2. PubMed ID: 13674387
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of antimony in multiple myeloma.
    RUBINSTEIN MA
    Blood; 1949 Sep; 4(9):1068-72. PubMed ID: 18134771
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative studies on the efficacy of pentamidine, Solustibosan and Neostibosan against Candida albicans].
    IVADY G; FRIEDRICH E
    Dtsch Gesundheitsw; 1960 Oct; 15():2130-2. PubMed ID: 13718206
    [No Abstract]   [Full Text] [Related]  

  • 57. Activity of certain diamidines against blastomycosis and Candida infection in mice.
    SOLOTOROVSKY M; IRONSON EJ; GREGORY FJ; WINSTEN S
    Antibiot Chemother (Northfield); 1954 Feb; 4(2):165-8. PubMed ID: 24542893
    [No Abstract]   [Full Text] [Related]  

  • 58. [Recent observations in myeloma patients with special consideration of treatment with stilbamidine and pentamidine].
    HEILMEYER L
    Schweiz Med Wochenschr; 1949 Sep; 79(36):837. PubMed ID: 18148452
    [No Abstract]   [Full Text] [Related]  

  • 59. The pharmacology, mode of action and therapeutic potentialities of stilbamidine, pentamidine, propamidine and other aromatic diamidines a review.
    SCHOENBACH EB; GREENSPAN EM
    Medicine (Baltimore); 1948 Sep; 27(3):327-77. PubMed ID: 18885033
    [No Abstract]   [Full Text] [Related]  

  • 60. Endogenous endophthalmitis with azole-resistant Candida albicans--Case report and review of the literature.
    Osthoff M; Hilge R; Schulze-Döbold C; Bogner JR
    Infection; 2006 Oct; 34(5):285-8. PubMed ID: 17033755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.